The aim of the study was to investigate 4-year outcomes and predictors of repeat revascularization in patients treated with the Resolute zotarolimus-eluting stent ( R-ZES ) ( Medtronic , Minneapolis , Minnesota ) and XIENCE V everolimus-eluting stent ( EES ) ( Abbott Vascular , Abbott Park , Illinois ) in the RESOLUTE ( A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention ) All-Comers trial .